| Fenofibric acid Basic information |
| Product Name: | Fenofibric acid |
| Synonyms: | 2-[4-(4-CHLOROBENZOYL)PHENOXY]-2-METHYLPROPANOIC ACID;LABOTEST-BB LT00239222;FENOFIBRIC ACID;SALOR-INT L498335-1EA;2-[4-(4-CHLORO-BENZOYL)-PHENOXY]-2-METHYL-PROPIONIC ACID (FENOFIBRIC ACID);2-[4-(4-CHLOROBENBONYZOYL)PHENOXY)-2-METHYLPROPIONIC ACID;2-[4'-(p-Chlorobenzoyl)phenoxy]-2-methylpropionic acid;FENOFIBRATE ACID |
| CAS: | 42017-89-0 |
| MF: | C17H15ClO4 |
| MW: | 318.75 |
| EINECS: | 255-626-9 |
| Product Categories: | JANUVIA;Various Metabolites and Impurities;pharmacetical;Intermediates & Fine Chemicals;Metabolites & Impurities;Pharmaceuticals;Aromatics |
| Mol File: | 42017-89-0.mol |
| Fenofibric acid Chemical Properties |
| Melting point | 177-179°C |
| Boiling point | 486.5±35.0 °C(Predicted) |
| density | 1.286±0.06 g/cm3(Predicted) |
| storage temp. | 2-8°C |
| solubility | Chloroform (Slightly), Methanol (Slightly) |
| pka | 3.09±0.10(Predicted) |
| form | powder |
| color | White to Off-White |
| BRN | 2058973 |
| CAS DataBase Reference | 42017-89-0(CAS DataBase Reference) |
| Safety Information |
| Hazard Codes | Xn,N |
| Risk Statements | 36/37/38-50/53-22 |
| Safety Statements | 26-36/37/39-61-60-24/25 |
| RIDADR | UN 3077 9 / PGIII |
| WGK Germany | 3 |
| RTECS | UA2453000 |
| HazardClass | 9 |
| PackingGroup | III |
| HS Code | 29189900 |
| Toxicity | LD50 oral in rat: 1242mg/kg |
| MSDS Information |
| Fenofibric acid Usage And Synthesis |
| Chemical Properties | White to Off-White Solid |
| Uses | Fenofibric acid, the active metabolite of fenofibrate. Increases Apolipoprotein A-Iediated High-Density Lipoprotein Biogenesis by enhancing transcription of ATP-Binding cassette transporter A1 gene in a liver X receptorependent manner |
| Uses | Fenofibric acid, the active metabolite of fenofibrate. Increases Apolipoprotein A-I–Mediated High-Density Lipoprotein Biogenesis by enhancing transcription of ATP-Binding cassette transporter A1 gene in a liver X receptor–dependent manner. |
| Uses | DPP4 inhibitor, antidiabetic |
| Definition | ChEBI: A monocarboxylic acid that is 2-methylpropanoic acid substituted by a 4-(4-chlorobenzoyl)phenoxy group at position 2. It is a metabolite of the drug fenofibrate. |
| Fenofibric acid Preparation Products And Raw materials |
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.
日本语
한국어
Français
Deutsch
España
Türkiye